Publications by authors named "Ningyi Xue"

Claim this Profile
P
Polycystin-1 Mutant Alters Mechanotransduction in Response to Collagen and Extracellular Matrix Stiffness via Daam1-Dependent Microfilament Remodeling.
Jiaofeng Zhou, Yibing Deng, Jie Mei, Mengyun Wan, Ningyi Xue

Adv Sci (Weinh)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple-Negative Breast Cancer.
Mengyun Wan, Jie Mei, Yun Cai, Ji Zhou, Ningyi Xue

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic signature for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
Yincheng Liu, Ningyi Xue, Feidie Duan, Kunli Zhao, Yan Liang

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer.
Yincheng Liu, Ningyi Xue, Yuelin Liu, Jie Mei, Yun Cai

Transl Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lovastatin-mediated pharmacological inhibition of Formin protein DIAPH1 suppresses tumor immune escape and boosts immunotherapy response.
Mengyun Wan, Ji Zhou, Ningyi Xue, Jie Mei, Jiaofeng Zhou

Int Immunopharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy.
Minghui Li, Yuelin Liu, Xu Han, Tao Li, Zhizheng Zhang, Ningyi Xue

Breast Cancer (Dove Med Press)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade.
Jie Mei, Jiahui Chu, Kai Yang, Zhiwen Luo, Jiayue Yang, Ningyi Xue

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis